London
10 °C
Manchester
Glasgow
2 °C
Dublin
Belfast
Washington
17 °C
Denver
Atlanta
Dallas
Houston Texas
New Orleans
El Paso
Phoenix
Los Angeles
15 °C
5 °C
17 °C
23 °C
3 °C
12 °C
12 °C
24 °C
Featured
Last news
What we know about deadly Delhi car blast
India has vowed to bring to justice the "perpetrators, their collaborators, and their sponsors" behind the deadliest explosion in the nation's capital for more than a decade.
Peru's interim president embraces the spotlight in 'war' on crime
Like a veritable action hero, Peru's interim president rolls up his sleeves to take part in nighttime raids on prisons and in the street, always making sure his bravado is captured on camera.
Medicus Pharma Ltd. Provides Corporate Updates and Reports Third Quarter 2025 Financial Highlights
Clinical development programs for doxorubicin-containing microneedle array (D-MNA) and Teverelix, a next generation GnRH antagonist, are steadily advancing
Pet-Food Revolution: Two New Global Surveys Reveal Growing Guardian Openness to Sustainable Diets for Dogs and Cats
LONDON, UK / ACCESS Newswire / November 14, 2025 / Two pioneering studies published in the journal Animals have explored in depth how dog and cat guardians perceive more sustainable pet food options. Led by Jenny L. Mace, Alexander Bauer, Andrew Knight and Billy Nicholles, the research sheds new light on the potential for alternative proteins and plant-based diets in the companion animal sector.
Wellgistics Health to Distribute Tollo Health GLP-1 Companion Muscle Loss Medical Food to Pharmacies & Physicians
Company to offer the first clinically validated dietary management of sarcopenia, now available for GLP-1 muscle loss, positioning Wellgistics to help 6,500+ independent pharmacy network (‘Pharmacy Network') and telehealth partners mitigate patient muscle loss in the GLP-1 drug market, estimated to grow to $150 billion by 2030Company to offer first SARS-CoV-2 related natural antiviral combo for Long COVID with addition of 3CL protease inhibitor supplement Tollovid® to Galectovid 1 & 3 inhibitor Medical Food Galectovid® distribution agreement to Pharmacy Network & physicians
Jaguar Health to Hold Investor Webcast Monday, November 17 at 8:30 AM Eastern Regarding Q3 2025 Financials & Corporate Updates
Click here to registerCompany plans to file its Earnings Report on November 14, 2025 on Form 10-Q for the quarter ended September 30, 2025
NanoViricides to Present at the Pharma Partnering Summit 2025 in Boston Today, November 14th - NV-387 is Effective Against H3N2
SHELTON, CONNECTICUT / ACCESS Newswire / November 14, 2025 / NanoViricides, Inc. (NYSE American:NNVC) (the "Company"), a clinical stage leader developing revolutionary broad-spectrum antiviral drugs that the virus cannot escape, announced that it will be presenting today, Friday, November 14th, at 11:25am ET at the Pharma Partnering Summit 2025 held at the Hilton Boston Logan Airport in Boston, MA.
TRNR Reports Record Third Quarter 2025 Results with 139% YoY Growth; Reiterates 2025 Pro Forma Revenue Guidance of $80M+ To Be Driven by Completion of Sportstech Acquisition
Quarterly Results Reflect First Full Quarter Including Wattbike (Acquisition Closed July 1)Company Reports Record Quarterly Revenue of $4.8 Million; Net Loss and Loss per Diluted Share of $5.2 Million and $3.11; Quarterly Adjusted EBITDA Loss of $2.9 million, Due to Low Inventory AvailabilitySportstech Acquisition Expected to Close in 2025 Based on Key Closing Milestone AchievementsReiterates 2025 Pro Forma Revenue Guidance of more than $80 million and Fourth Quarter Profitability Guidance
Europe court orders Poland pay damages to woman who aborted abroad
Europe's top rights court Thursday ruled that Poland had interfered with the private life of a woman who had an abortion abroad because she was unsure it was legal at home.
EU lawmakers back proxy voting for pregnant women, new mothers
Pregnant lawmakers and new mothers will get the right to vote by proxy in the European Parliament under a rule change backed Thursday by the assembly, and now headed to member states for approval.
Pakistan grants lifetime immunity to president, current army chief
Pakistan's parliament approved a sweeping constitutional amendment on Thursday granting lifetime immunity to the president as well as the current army chief, a move critics warned would erode democratic checks and judicial independence.
Electronic Caregiver Announces Breakthrough Results from National Medicare Test of Addison Care(R), Demonstrating Unprecedented Patient Engagement, High Reliability, and Scalability for Nationwide Rollout
LAS CRUCES, NEW MEXICO / ACCESS Newswire / November 13, 2025 / Electronic Caregiver, Inc. today announced outstanding clinical performance from a multi-state Medicare service test of Addison Care®, the industry's first 3D Virtual Caregiver designed to support chronically ill older adults at home with 24/7 intelligent care, guidance, and daily engagement.
Newsmax Announces Third Quarter 2025 Financial Results
Company Reports Revenues of $45.3 million, a 4.0% Year-Over-Year Increase, Outpacing Election-Year ComparisonBroadcast Revenues Increase to $36.6 Million, a 10.1% Increase Year-Over-YearNewsmax Remains the Fourth Highest-Rated Cable News Channel With Over 28 Million Quarterly Viewers
HPB and Coperion Partner on Next-Generation Slurry Production
New to The Street will be covering across all media.
Jaguar Health Provides Recap of November 8, 2025 Presentation on Groundbreaking Results of Proof-of-Concept Study of Crofelemer for Treatment of Pediatric Intestinal Failure at NASPGHAN Annual Meeting
Crofelemer can potentially extend and save lives of microvillus inclusion disease patients, reducing the volume of the total parenteral support (PS) necessary for them to surviveGroundbreaking PS reduction of up to 37% is unprecedented; No approved treatments exist for MVID
Entero's Grid AI Prepares for Major U.S. Expansion with New Leadership Appointments to Accelerate AI Infrastructure Strategy
Timed with a sharp acceleration in AI-data-center expansion, with more than $60B in new projects announced in the last 90 days.
Medicus Pharma Ltd. Receives Full United Kingdom Regulatory and Ethical Approvals To Expand Phase 2 Clinical Study (SKNJCT-003) To Non-Invasively Treat Basal Cell Carcinoma (BCC) of the Skin
THE SKNJCT-003 CLINICAL STUDY EXPANSION INTO THE UNITED KINGDOM TO FURTHER ENABLE GLOBAL PATIENT RECRUITMENT AND CLINICAL DATASET TOWARD A PIVOTAL STUDY PROGRAM
US jury: Boeing owes $28 mn to family of Ethiopian Airlines crash victim
A US jury in the first civil trial over a fatal Boeing 737 MAX crash determined Wednesday that the aircraft manufacturing giant owes $28.45 million to the family of a newly-wed Indian victim.
Back on track: Belgian-Dutch firm rescues Berlin to Paris sleeper train
Railway fans devastated by the scrapping of a much-heralded Berlin to Paris night train can breathe again after a Belgian-Dutch cooperative stepped in Wednesday to keep the service going.
Algeria pardons writer Boualem Sansal
Algeria has pardoned French-Algerian writer Boualem Sansal after a request from Germany, to where he will be transferred for medical treatment after a year in detention, it was announced Wednesday.
Pope Leo reels off four favourite films
Pope Leo XIV has revealed his four favourite films ahead of a special audience with Hollywood celebrities and Oscar-winning directors at the Vatican.
Pakistan tightens Islamabad security after suicide blast
Residents in the Pakistani capital Islamabad were facing tightened security checks on Wednesday in the wake of a suicide bombing that left top officials vowing to halt the rise in deadly attacks.
Corruption scandal, court battles pose test for Zelensky
A major corruption scandal and mounting accusations that the Ukrainian presidency is using the judiciary to intimidate and silence critics has rocked Kyiv, presenting a significant test for Volodymyr Zelensky almost four years into the Russian invasion.
DR Congo ex-rebel leader Lumbala's war crimes trial opens in Paris
Former Congolese rebel leader Roger Lumbala goes on trial in Paris Wednesday over atrocities committed in the Democratic Republic of Congo's bloody eastern conflict more than two decades ago.
Cambodia's Prince Group denies link to scams after asset seizures
A Cambodian conglomerate whose founder has had more than $15 billion of allegedly ill-gotten assets seized said it "categorically rejects" claims he amassed his fortune running an internet scam empire.
Ousted Gabon leader's wife and son sentenced to 20 years for graft
A Gabon court on Wednesday sentenced the former first lady and son of the oil-rich country's deposed leader Ali Bongo to 20 years in prison following a two-day graft trial.
Bangladesh's liquor industry a surprising success
Syrupy aromas drift across the guarded compound of Bangladesh's only licensed distillery, a state-owned producer posting record profits in the Muslim-majority nation, where Islamists are staging a political comeback.
Electronic Caregiver's Addison Care(R): As OpenAI Considers Consumer Health Devices, the Future Is Already Here
LAS CRUCES, NEW MEXICO / ACCESS Newswire / November 12, 2025 / Following reports that OpenAI is exploring the launch of consumer health devices and monitoring tools, Electronic Caregiver, Inc. ("ECG"), developer of the Addison Care® virtual caregiver and TeleCare ecosystem, confirms that the future these AI giants are racing toward has already been built and is in market today.
NanoViricides Announces Closing of $6 Million Registered Direct Offering and Concurrent Private Placement Priced at the Market Close
SHELTON, CONNECTICUT / ACCESS Newswire / November 12, 2025 / NanoViricides, Inc. (NYSE American:NNVC) (the "Company"), today announced the closing of its previously announced securities purchase agreement with a single healthcare institutional investor for the purchase and sale of 3,571,429 shares of common stock (or common stock equivalents in lieu thereof) at a purchase price of $1.68 per share in a registered direct offering (the "Offering"). The gross proceeds from the Offering are approximately $6 million, before deducting placement agent commissions and other offering expenses. In addition, in a concurrent private placement, the Company has issued and sold Series A warrants to purchase up to 3,571,429 shares of common stock (the "Series A Warrants") and Series B warrants to purchase up to 3,571,429 shares of common stock (the "Series B Warrants" and, together with the Series A Warrants, the "Warrants"). The Series A Warrants have an exercise price of $1.75 per share, are exercisable after 6 months from date of issuance, and expire 2 years following the issuance date. The Series B Warrants have an exercise price of $2.00 per share, are exercisable after 6 months from date of issuance, and expire 5.5 years following the issuance date. The exercise price of the Series B Warrants represents approximately a 20% premium to the closing price for the Company's common stock on November 10, 2025.
iTolerance CEO, Anthony Japour, Receives BioFlorida's Research & Developer of the Year Award
MIAMI, FL / ACCESS Newswire / November 12, 2025 / iTolerance, Inc. ("iTolerance" or the "Company"), an early-stage privately-held biotechnology company focused on the development of innovative regenerative medicines, today announced that Anthony Japour, Chief Executive Officer and President of iTolerance, received the Research & Developer of the Year Award at the recently held BioFlorida Innovation Conference in Miami, FL.
Telomir Pharmaceuticals Reports Telomir-1 Outperforms FDA-Approved Gold-Standard Iron Chelator Deferoxamine (DFO) in Reducing Intracellular Iron in a Human Cell Line
New live-cell imaging data show that Telomir-1 markedly lowers intracellular iron levels at submicromolar concentrations in human keratinocytes, demonstrating potent cell penetration and iron-modulating activity - key to its broader epigenetic mechanism of action.
Dalet Named a Major Player in the 2025 IDC MarketScape for Worldwide Media Production, Distribution, and Monetization Integrated Cloud Solutions
NEW YORK, US / ACCESS Newswire / November 12, 2025 / Dalet, a leading provider of cloud-native, end-to-end media workflow solutions, today announced that it has been recognized as a Major Player in the IDC MarketScape: Worldwide Media Production, Distribution, and Monetization Integrated Cloud Solutions 2025 Vendor Assessment*. The report evaluates technology vendors helping media organizations streamline production, distribution, and monetization through unified cloud platforms.